SANGAMO THERAPEUTICS, INC (SGMO) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
SGMO currently has 390M outstanding shares. with minimal authorized share overhang for future dilution. The company has significantly diluted shareholders by 83.99% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 389.6M shares outstanding |
390M | 0 |
| Mar 30, 2026 |
10-K filing | 414.3M shares outstanding |
410M | 0 |
| Nov 06, 2025 |
10-Q filing | 304.3M shares outstanding |
300M | 39M |
| Aug 07, 2025 |
10-Q filing | 301.7M shares outstanding |
300M | 42M |
| May 13, 2025 |
8-K filing: Sangamo Therapeutics, Inc. entered into an underwriting agreement for the issuance and sale of 12,235,000 shares of common stock and pre-funded warrants to purchase 34,398,393 shares of common stock, along with accompanying warrants to purchase 46,633,393 shares of common stock, with an expected gross proceeds of approximately $23.0 million before deducting underwriting discounts and estimated offering expenses; the offering is expected to close on May 14, 2025. ($23.0M proceeds) |
220M | 120M |
| May 12, 2025 |
10-Q filing | 220.3M shares outstanding |
220M | 120M |
| Mar 17, 2025 |
10-K filing | 224.7M shares outstanding |
220M | 120M |
| Nov 12, 2024 |
10-Q filing | 208.3M shares outstanding |
210M | 130M |
| Nov 12, 2024 |
S-3 filing: The company files an S-3 to offer and sell up to $500,000,000 of common stock, preferred stock, and/or debt securities from time to time. |
200M | 140M |
| Aug 06, 2024 |
10-Q filing | 203.9M shares outstanding |
200M | 0 |
| May 09, 2024 |
10-Q filing | 207.5M shares outstanding |
210M | 0 |
| Mar 13, 2024 |
10-K filing | 174.4M shares outstanding |
170M | 0 |
| Nov 01, 2023 |
10-Q filing | 177.2M shares outstanding |
180M | 0 |
| Aug 08, 2023 |
10-Q filing | 174.3M shares outstanding |
170M | 0 |
| May 08, 2023 |
10-Q filing | 169.2M shares outstanding |
170M | 0 |
| Feb 23, 2023 |
10-K filing | 154.3M shares outstanding |
150M | 3.7M |
| Feb 23, 2023 |
POS AM filing: The filing is a POS AM filing for a potential offering of up to $500,000,000 of common stock, preferred stock, debt securities, or warrants. |
160M | 0 |
| Nov 03, 2022 |
10-Q filing | 158.0M shares outstanding |
160M | 0 |
| Aug 04, 2022 |
10-Q filing | 148.2M shares outstanding |
150M | 0 |
| May 05, 2022 |
10-Q filing | 146.2M shares outstanding |
150M | 0 |
| Feb 24, 2022 |
10-K filing | 144.6M shares outstanding |
140M | 0 |
| Nov 04, 2021 |
10-Q filing | 145.4M shares outstanding |
150M | 0 |
| Aug 05, 2021 |
10-Q filing | 144.0M shares outstanding |
140M | 0 |
| May 04, 2021 |
10-Q filing | 143.9M shares outstanding |
140M | 0 |
| Feb 24, 2021 |
10-K filing | 143.3M shares outstanding |
140M | 0 |
| Nov 04, 2020 |
10-Q filing | 141.4M shares outstanding |
140M | 0 |
| Aug 05, 2020 |
10-Q filing | 141.0M shares outstanding |
140M | 0 |
| May 11, 2020 |
10-Q filing | 140.9M shares outstanding |
140M | 0 |
| Feb 28, 2020 |
10-K filing | 116.0M shares outstanding |
120M | 0 |